$7.38
-0.40-5.08%
Last update: Aug 20, 1:03 PM
Entrada Therapeutics Inc
TRDANASDAQ
Entrada Therapeutics Earnings & Forecasts
Entrada Therapeutics (TRDA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Entrada Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.07 | $-1.03 | $-1.22 | $-0.99 |
| Actual | $-1.01 | $-0.95 | $-0.94 | $-1.06 |
| Surprise | +5.61% | +7.77% | +22.9% | -7.07% |
| Revenue | ||||
| Estimate | $2.0M | $3.6M | $5.0M | $7.3M |
| Actual | $898000 | $875000 | $1.3M | $1.6M |
| Surprise | -54.3% | -75.8% | -73.8% | -78.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.98 | $-0.90 | $-0.95 | $-0.85 |
| Revenue | ||||
| Consensus | $5.8M | $10.1M | — | — |
